JP2001507021A5 - - Google Patents

Download PDF

Info

Publication number
JP2001507021A5
JP2001507021A5 JP1998528670A JP52867098A JP2001507021A5 JP 2001507021 A5 JP2001507021 A5 JP 2001507021A5 JP 1998528670 A JP1998528670 A JP 1998528670A JP 52867098 A JP52867098 A JP 52867098A JP 2001507021 A5 JP2001507021 A5 JP 2001507021A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
JP1998528670A
Other languages
English (en)
Japanese (ja)
Other versions
JP2001507021A (ja
Filing date
Publication date
Priority claimed from SE9604786A external-priority patent/SE9604786D0/xx
Application filed filed Critical
Publication of JP2001507021A publication Critical patent/JP2001507021A/ja
Publication of JP2001507021A5 publication Critical patent/JP2001507021A5/ja
Ceased legal-status Critical Current

Links

JP52867098A 1996-12-20 1997-12-09 鎮痛作用を有する新規な化合物 Ceased JP2001507021A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE9604786-5 1996-12-20
SE9604786A SE9604786D0 (sv) 1996-12-20 1996-12-20 New compounds
PCT/SE1997/002051 WO1998028270A1 (en) 1996-12-20 1997-12-09 Novel compounds with analgesic effect

Publications (2)

Publication Number Publication Date
JP2001507021A JP2001507021A (ja) 2001-05-29
JP2001507021A5 true JP2001507021A5 (enExample) 2005-08-11

Family

ID=20405139

Family Applications (1)

Application Number Title Priority Date Filing Date
JP52867098A Ceased JP2001507021A (ja) 1996-12-20 1997-12-09 鎮痛作用を有する新規な化合物

Country Status (31)

Country Link
US (3) US6153626A (enExample)
EP (2) EP0946510B1 (enExample)
JP (1) JP2001507021A (enExample)
KR (1) KR20000069600A (enExample)
CN (2) CN1154635C (enExample)
AR (1) AR010378A1 (enExample)
AT (1) ATE266638T1 (enExample)
AU (1) AU738002B2 (enExample)
BR (1) BR9713785A (enExample)
CA (1) CA2274117A1 (enExample)
CZ (1) CZ220099A3 (enExample)
DE (1) DE69729115T2 (enExample)
DK (1) DK0946510T3 (enExample)
EE (1) EE03966B1 (enExample)
ES (1) ES2219783T3 (enExample)
HU (1) HUP0000613A3 (enExample)
ID (1) ID21662A (enExample)
IL (1) IL130536A0 (enExample)
IS (1) IS5078A (enExample)
MY (1) MY132705A (enExample)
NO (1) NO313632B1 (enExample)
NZ (1) NZ336028A (enExample)
PL (1) PL188945B1 (enExample)
PT (1) PT946510E (enExample)
RU (1) RU2193030C2 (enExample)
SE (1) SE9604786D0 (enExample)
SK (1) SK283300B6 (enExample)
TR (1) TR199901411T2 (enExample)
UA (1) UA54481C2 (enExample)
WO (1) WO1998028270A1 (enExample)
ZA (1) ZA9711049B (enExample)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9504661D0 (sv) 1995-12-22 1995-12-22 Astra Pharma Inc New compounds
SE9604786D0 (sv) * 1996-12-20 1996-12-20 Astra Pharma Inc New compounds
TW548271B (en) * 1996-12-20 2003-08-21 Astra Pharma Inc Novel piperidine derivatives having an exocyclic double bond with analgesic effects
US6974825B1 (en) 1996-12-20 2005-12-13 Astrazeneca Canada Inc. Compounds with analgesic effect
JP4754068B2 (ja) * 1997-12-24 2011-08-24 オーソ−マクニール・フアーマシユーチカル・インコーポレーテツド δ−オピオイドレセプターに結合する4−[アリール(ピペリジン−4−イル)]アミノベンズアミド類
AU2003220725B2 (en) * 1997-12-24 2006-06-01 Ortho-Mcneil Pharmaceutical, Inc. 4-[aryl(piperidin-4-yl)] aminobenzamides which bind to the delta-opioid receptor
EP1512683B1 (en) * 1998-03-10 2011-08-31 Research Triangle Institute Novel opiate compounds, methods of making and methods of use
US6900228B1 (en) * 1998-03-10 2005-05-31 Research Triangle Institute Opiate compounds, methods of making and methods of use
US6436959B1 (en) 1998-12-23 2002-08-20 Ortho-Mcneil Pharmaceutical, Inc. 4-[aryl(piperidin-4-yl)]aminobenzamides
SE9904675D0 (sv) 1999-12-20 1999-12-20 Astra Pharma Inc Novel compounds
SE9904674D0 (sv) * 1999-12-20 1999-12-20 Astra Pharma Inc Novel compounds
SE9904673D0 (sv) 1999-12-20 1999-12-20 Astra Pharma Inc Novel compounds
JP2003518119A (ja) * 1999-12-22 2003-06-03 オーソ−マクニール・フアーマシユーチカル・インコーポレーテツド 4−[アリール(8−アザビシクロ[3.2.1]オクタン−3−イル)]アミノ安息香酸誘導体
CA2400640A1 (en) * 2000-02-18 2001-08-23 Meiji Seika Kaisha, Ltd. Phenoxyalkylamine derivatives useful as opioid .delta. receptor ligands
IL151550A0 (en) 2000-03-03 2003-04-10 Ortho Mcneil Pharm Inc 3-(diarylmethylene)-8-azabicyclo [3.2.1] octane derivatives
US6790854B2 (en) 2000-03-24 2004-09-14 Meiji Seika Kaisha, Ltd. Diphenylalkylamine derivatives useful as opioid receptor agonists
SE0001209D0 (sv) 2000-04-04 2000-04-04 Astrazeneca Canada Inc Novel compounds
AU2002234010A1 (en) * 2000-12-14 2002-06-24 Ortho-Mcneil Pharmaceutical, Inc. Benzamidine derivatives
JP2004515539A (ja) * 2000-12-15 2004-05-27 アストラゼネカ・アクチエボラーグ ジアリール−4−アミノ−ピペリジニル化合物の新しい調製方法
WO2002094794A1 (en) 2001-05-18 2002-11-28 Astrazeneca Ab 4 (phenyl-piperazinyl-methyl) benzamide derivatives and their use for the treatment of pain anxiety or gastrointestinal disorders
SE0101769D0 (sv) * 2001-05-18 2001-05-18 Astrazeneca Ab Novel compounds
SE0101771D0 (sv) * 2001-05-18 2001-05-18 Astrazeneca Ab Novel compounds
SE0101773D0 (sv) * 2001-05-18 2001-05-18 Astrazeneca Ab Novel compounds
SE0101770D0 (sv) * 2001-05-18 2001-05-18 Astrazeneca Ab Novel compounds
NZ531679A (en) 2001-10-15 2005-02-25 Janssen Pharmaceutica Nv Novel substituted 4-phenyl-4-[1H-imidazol-2-YL]-piperidine derivatives and their use as selective non-peptide delta opioid agonists
KR20040090979A (ko) * 2002-03-13 2004-10-27 얀센 파마슈티카 엔.브이. 히스톤 데아세틸레이즈의 신규한 억제제
EP1507756B1 (en) 2002-05-24 2015-07-22 Millennium Pharmaceuticals, Inc. Ccr9 inhibitors and methods of use thereof
SE0203302D0 (sv) 2002-11-07 2002-11-07 Astrazeneca Ab Novel Compounds
SE0203303D0 (sv) 2002-11-07 2002-11-07 Astrazeneca Ab Novel Compounds
SE0203300D0 (sv) 2002-11-07 2002-11-07 Astrazeneca Ab Novel Compounds
US7227035B2 (en) 2002-11-18 2007-06-05 Chemocentryx Bis-aryl sulfonamides
US7741519B2 (en) 2007-04-23 2010-06-22 Chemocentryx, Inc. Bis-aryl sulfonamides
DK1798223T4 (da) 2002-11-18 2014-09-22 Chemocentryx Inc Arylsulfonamider
US7420055B2 (en) 2002-11-18 2008-09-02 Chemocentryx, Inc. Aryl sulfonamides
US7601740B2 (en) * 2003-01-16 2009-10-13 Acadia Pharmaceuticals, Inc. Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseases
UA86024C2 (ru) * 2003-06-27 2009-03-25 Янссен Фармацевтика Н.В. Трициклические дельта-опиоидные модуляторы
US7435822B2 (en) 2004-02-03 2008-10-14 Janssen Pharmaceutica N.V. 3-(diheteroarylmethylene)-8-azabicyclo[3.2.1]octane and 3-((aryl)(heteroaryl)methylene)-8-azabicyclo[3.2.1]octane derivatives
KR101234421B1 (ko) 2004-08-02 2013-02-18 아스트라제네카 아베 디아릴메틸 피페라진 유도체, 이의 제조 방법 및 용도
CA2574768A1 (en) * 2004-08-05 2006-02-05 Janssen Pharmaceutica N.V. Tricyclic delta-opioid modulators
US20060135522A1 (en) * 2004-12-22 2006-06-22 Carson John R Tricyclic delta-opioid modulators
CA2591963A1 (en) * 2004-12-22 2006-06-29 Janssen Pharmaceutica N.V. Tricyclic o-opioid modulators
US7589104B2 (en) * 2004-12-22 2009-09-15 Janssen Pharmaceutica Nv Tricyclic-bridged piperidinyline derivatives as §-opioid modulators
JP2008526878A (ja) * 2005-01-06 2008-07-24 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ 三環式δ−オピオイド調節剤
TWI449692B (zh) * 2005-05-13 2014-08-21 Otsuka Pharma Co Ltd 吡咯烷化合物(三)
DE602006018604D1 (de) * 2005-06-16 2011-01-13 Janssen Pharmaceutica Nv Tricyclische opioidmodulatoren
JP5219465B2 (ja) * 2006-11-10 2013-06-26 大塚製薬株式会社 医薬

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4091096A (en) * 1976-03-19 1978-05-23 Eli Lilly And Company Dinitroanilines for the control of phytopathogens
EG12406A (en) * 1976-08-12 1979-03-31 Janssen Pharmaceutica Nv Process for preparing of novel n-aryl-n-(1-l-4-piperidinyl)-arylacetamides
SE441448B (sv) * 1977-05-23 1985-10-07 Pfizer Sett att framstella hexahydro-gamma-karbolinforeningar
DE3200304A1 (de) * 1981-01-16 1982-08-26 Sandoz-Patent-GmbH, 7850 Lörrach 3-aminopropoxyaryl-derivate, ihre herstellung und sie enthaltende arzneimittel
DE3563964D1 (en) * 1984-10-16 1988-09-01 Synthelabo Piperidine derivatives, their preparation and their therapeutical application
KR940003491B1 (ko) 1989-08-10 1994-04-23 리히터 게데온 베기에스제티 기아르 알.티 4,4-이중 치환된 피페리딘 유도체와 그 제조방법 및 상기 화합물을 함유하는 약제학적 조성물
YU150489A (sh) 1989-08-10 1992-12-21 W.L. Gore & Co. Gmbh. Uređaj za ispitivanje odevnih predmeta na nepromočivost
SE8904298D0 (sv) * 1989-12-21 1989-12-21 Astra Ab New compounds
GB9202238D0 (en) * 1992-02-03 1992-03-18 Wellcome Found Compounds
US5854245A (en) * 1996-06-28 1998-12-29 Merck & Co., Inc. Fibrinogen receptor antagonists
SE9604786D0 (sv) 1996-12-20 1996-12-20 Astra Pharma Inc New compounds
TW548271B (en) * 1996-12-20 2003-08-21 Astra Pharma Inc Novel piperidine derivatives having an exocyclic double bond with analgesic effects
JP4754068B2 (ja) * 1997-12-24 2011-08-24 オーソ−マクニール・フアーマシユーチカル・インコーポレーテツド δ−オピオイドレセプターに結合する4−[アリール(ピペリジン−4−イル)]アミノベンズアミド類
EP1512683B1 (en) 1998-03-10 2011-08-31 Research Triangle Institute Novel opiate compounds, methods of making and methods of use
US6436959B1 (en) 1998-12-23 2002-08-20 Ortho-Mcneil Pharmaceutical, Inc. 4-[aryl(piperidin-4-yl)]aminobenzamides

Similar Documents

Publication Publication Date Title
JP2000511342A5 (enExample)
JP2000506670A5 (enExample)
JP2001507641A5 (enExample)
JP2000512167A5 (enExample)
JP2001504101A5 (enExample)
JP2000514202A5 (enExample)
JP2000511898A5 (enExample)
JP2001512478A5 (enExample)
JP2000510701A5 (enExample)
JP2000504625A5 (enExample)
JP2001501097A5 (enExample)
JP2001504696A5 (enExample)
JP2001511826A5 (enExample)
JP2000511907A5 (enExample)
JP2000509395A5 (enExample)
JP2001506658A5 (enExample)
JP2001507021A5 (enExample)
JP2000511540A5 (enExample)
JP2000511125A5 (enExample)
JP2000511877A5 (enExample)
JP2001502002A5 (enExample)
JP2001503400A5 (enExample)
JP2000508653A5 (enExample)
JP2000505684A5 (enExample)
JP2000510147A5 (enExample)